Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?

Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies

(2010) Jia-Yi Dong et al.   BREAST CANCER RESEARCH AND TREATMENT

In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole

(2010) Landry K. Kamdem et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

In Vitro Cytochrome P450-Mediated Metabolism of Exemestane

(2010) L. K. Kamdem et al.   DRUG METABOLISM AND DISPOSITION

The pros and cons of phytoestrogens

(2010) Heather B. Patisaul et al.   FRONTIERS IN NEUROENDOCRINOLOGY

Prospective study of the association between grapefruit intake and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)

(2009) Elizabeth A. Spencer et al.   CANCER CAUSES & CONTROL

Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer

(2008) Christine M Mueller et al.   BMC Complementary and Alternative Medicine

Use of complementary therapies by Australian women with breast cancer

(2008) T. Kremser et al.   BREAST

Familial and Perceived Risk of Breast Cancer in Relation to Use of Complementary Medicine

(2008) C. D. Myers et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Phytoestrogens and breast cancer: a complex story

(2008) W. G. Helferich et al.   INFLAMMOPHARMACOLOGY